Ignite Creation Date:
2024-05-05 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00524147
Status:
COMPLETED
Last Update Posted:
2010-12-30
First Post:
2007-08-31
Brief Title:
Drainage of Tuberculous Pleural Effusions
Sponsor:
Taipei Medical University Hospital
Organization:
Taipei Medical University Hospital
Study Overview
Official Title:
Drainage of Tuberculous Pleural Effusions
Status:
COMPLETED
Status Verified Date:
2010-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Tuberculous TB pleurisy can cause clinical symptoms and pleural fibrosis with resultant residual pleural thickening RPT Therapeutic thoracentesis or initial complete drainage in addition to anti-TB drugs have been tried to rapidly relieve dyspnea caused by effusion and to decrease the occurrence of RPT However contradictory results are reported without clear reasons The researchers hypothesis is that in addition to anti-TB medications early effective evacuation of inflammatory exudates with or without fibrinolytic agents may hasten resolution of pleural effusion reduce the occurrence of RPT and finally improve long-term functional outcome in patients with TB pleurisy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None